0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Endoscopic Submucosal Dissection Market by Product, Procedure Type, Indication Type, Disease Condition, End-User Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5789008
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Endoscopic Submucosal Dissection Market grew from USD 412.94 million in 2024 to USD 436.60 million in 2025. It is expected to continue growing at a CAGR of 5.94%, reaching USD 583.88 million by 2030.

Pioneering the Frontier of Endoscopic Submucosal Dissection

Endoscopic Submucosal Dissection has emerged as a game-changing intervention within minimally invasive gastrointestinal oncology, offering clinicians the ability to remove early-stage lesions with unparalleled precision. As gastrointestinal malignancies continue to pose significant global health challenges, ESD provides a path to improved patient outcomes, reduced hospital stays, and minimized procedural risks. This advanced technique harnesses refined endoscopic tools to dissect submucosal layers, enabling complete en bloc resection of lesions that previously required more invasive surgical approaches. Its growing adoption reflects an industry driven by technological maturation, clinician expertise, and patient demand for less traumatic interventions.

The evolving landscape of gastrointestinal interventions underscores the urgency for stakeholders-manufacturers, healthcare providers, and payers-to grasp the nuances of ESD’s rise. From accessory device innovation to procedural refinements, the trajectory of this market is shaped by multifaceted forces. In this executive summary, we explore the technological underpinnings, market dynamics, and emerging trends that define the current and future states of ESD. By examining key shifts, regulatory influences, segmentation data, and regional patterns, we aim to equip decision-makers with the critical insights necessary to navigate this complex, high-growth environment. The following sections provide an in-depth analysis designed to support strategic planning and foster informed investment in the endoscopic submucosal dissection arena.

Unveiling the Forces Redefining the ESD Landscape

The landscape of endoscopic submucosal dissection is undergoing transformative shifts driven by breakthroughs in device design, digital integration, and clinical protocols. Cutting-edge endoscopy platforms now feature enhanced imaging modalities, such as high-definition narrow-band imaging and augmented reality overlays, which empower physicians to delineate lesion margins with unprecedented accuracy. Parallel advances in accessory devices, including novel knife geometries and enhanced insufflation techniques, are accelerating procedural efficiency and safety.

Beyond technology, the surgeon’s skill set is evolving through comprehensive training programs and simulation-based curricula. Centers of excellence are emerging, fostering cross-institutional collaborations that accelerate best practice dissemination. Additionally, the integration of artificial intelligence into lesion detection and risk stratification is poised to optimize patient selection and procedural planning. On the reimbursement front, payers are increasingly recognizing the long-term value proposition of ESD as an outpatient procedure, prompting favorable coding revisions and bundled payment models. These collective shifts are recalibrating clinical pathways, incentivizing early intervention, and underscoring the market’s momentum.

Stakeholders must remain vigilant to these accelerators of change and adapt strategic roadmaps accordingly, aligning product development and market access initiatives with the currents reshaping the ESD domain.

Assessing the Ripple Effect of New 2025 US Tariffs

The introduction of updated United States tariffs in 2025 has created a measurable ripple effect across the endoscopic submucosal dissection supply chain. Import duties on specialized endoscopic instruments and componentry have risen, prompting manufacturers to reassess sourcing strategies and cost structures. Some device developers have relocated certain production phases closer to domestic or duty-exempt regions, seeking to mitigate margin compression. At the same time, distributors and hospital procurement teams are navigating pricing fluctuations, negotiating longer-term supply contracts to stabilize unit costs and ensure stock continuity.

These tariff-driven adjustments have also influenced competitive dynamics. Companies with vertically integrated models or diversified manufacturing footprints have leveraged cost advantages to maintain market share, while smaller suppliers face heightened pressure to streamline operations or pursue strategic partnerships. Downstream, the incremental cost increases are being absorbed variably by payers, with some healthcare systems opting to shift toward outcome-based reimbursement frameworks to justify higher procedural expenses.

As tariffs evolve, close monitoring of trade policy developments and proactive engagement with customs and regulatory bodies will be essential. Manufacturers and healthcare purchasers alike must adopt agile procurement models and explore local manufacturing alliances to shield their supply chains from future trade disruptions.

Decoding Market Dynamics through Precise Segmentation Insights

Decoding the complexities of the endoscopic submucosal dissection market begins with a nuanced understanding of its segmentation. Analysis based on product reveals two principal categories: accessory devices and endoscopy platforms. Accessory devices encapsulate everything from cap and hood attachments to forceps and clips, refined injection needles, insufflation units, versatile trocars, and an array of precision knives. Within knife offerings, distinctions emerge among dual, flex, hook, insulation-tipped, and triangle-tipped designs, each optimized for specific lesion characteristics. The endoscopy platforms themselves break down into colonoscopes, duodenoscopes, and gastroscopes, reflecting the varied anatomical applications of ESD.

Procedural segmentation highlights three core approaches: full-thickness resection, hybrid ESD, and partial-thickness resection. Each procedure type aligns with different clinical imperatives, balancing resection depth against risk profiles. Indication-based segmentation further refines the landscape, encompassing colorectal cancer, early gastric cancer-the latter subdivided into diffuse and intestinal types-as well as esophageal and broader gastric malignancies. Disease condition analysis distinguishes benign tumors, malignant tumors with invasive and non-invasive subtypes, and polyps, illustrating the full spectrum of lesion pathology addressed by ESD. Finally, end-user segmentation spans ambulatory surgical centers, hospitals, and specialty clinics, each with distinct procedural volumes, infrastructural requirements, and payer interactions. Through this multilayered framework, stakeholders can pinpoint priority areas for innovation, investment, and market entry.

Navigating Geographic Nuances in the ESD Domain

The expansion of endoscopic submucosal dissection is uneven across global regions, shaped by diverse healthcare infrastructure, regulatory regimes, and economic conditions. In the Americas, strong reimbursement incentives, widespread adoption of minimally invasive techniques, and established distribution networks underpin robust market growth. North American centers of excellence in ESD have forged clinical pathways that serve as global benchmarks, reinforcing the region’s leadership in procedural volume and technological innovation.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts and cross-border collaborations are catalyzing broader ESD adoption. In Western Europe, centralized healthcare systems are enabling aggregated purchasing agreements, while emerging markets in Eastern Europe and the Gulf Cooperation Council are investing in specialist training and device procurement. Africa’s landscape remains heterogeneous, with leading urban centers driving initial uptake amid ongoing efforts to bolster regional clinical capacity.

In the Asia-Pacific realm, escalating incidence rates of gastric and colorectal cancers have fueled strong demand for ESD. Japan and South Korea, long-established pioneers of the technique, continue to refine procedural protocols and device portfolios. Meanwhile, China and Southeast Asian markets are investing heavily in domestic manufacturing and training initiatives to meet surging patient needs. These regional dynamics underscore the importance of tailored market strategies that account for unique regulatory, clinical, and economic environments.

Spotlight on Industry Trailblazers and Innovators

Industry leaders are deploying varied strategies to consolidate their positions in the endoscopic submucosal dissection ecosystem. Major incumbents have fortified their portfolios through targeted R&D investments, launching advanced accessory lines while enhancing endoscope optics and ergonomics. Strategic alliances with robotics firms and imaging technology providers are accelerating next-generation platform development, integrating automation and AI-driven lesion detection.

Mid-tier players are carving out niches by specializing in high-performance knives and insufflation systems that complement flagship endoscopy units. Some have pursued geographic expansion through licensing and distribution partnerships, focusing on emerging markets with strong growth trajectories. Collaborative agreements with training centers and key opinion leaders are further amplifying brand recognition and driving procedure adoption.

Meanwhile, nimble start-ups are advancing disruptive approaches, from biodegradable adjuncts to novel hemostasis solutions, tapping into unmet clinical needs and differentiating through intellectual property portfolios. Across the spectrum, robust pipelines, strategic M&A activity, and customer-centric service models are hallmarks of companies securing a competitive edge in this rapidly evolving market.

Strategic Imperatives for Leaders Aspiring to Excel

To prosper in the evolving ESD market, industry leaders must pursue a multipronged strategic agenda. First, investing in comprehensive training initiatives and digital education platforms will accelerate clinician proficiency and drive procedural volume. Companies should partner with leading medical institutions to develop simulation-based curricula and certification programs that establish benchmarks for safe and effective ESD practice.

Second, supply chain resilience must become a core competency. Diversifying manufacturing locations and forging alliances with regional producers can mitigate tariff impacts and geopolitical risks. At the same time, adopting advanced analytics for demand forecasting will optimize inventory management and reduce disruptions.

Third, stakeholders should engage payers early to demonstrate the long-term value of ESD through real-world evidence and health economics studies. Securing favorable reimbursement pathways and outcome-based payment models will underpin sustainable growth. Additionally, tailoring product portfolios to address specific regional and clinical nuances-such as knife configurations for early gastric cancer subtypes-will unlock differentiated market opportunities.

Finally, embracing digital transformation through AI-enabled imaging, remote proctoring, and integrated data platforms will enhance procedural efficiency and patient outcomes. By aligning these strategic imperatives, industry participants can strengthen their market position and catalyze the next wave of ESD adoption.

Rigorous Methodological Blueprint Driving Our Analysis

Our analysis draws upon a rigorous, multi-phased research methodology designed to deliver robust, actionable insights. The process commenced with an exhaustive review of secondary sources, including peer-reviewed journals, regulatory filings, patent databases, and company financial disclosures. This foundation was complemented by in-depth primary interviews with key opinion leaders, endoscopy specialists, procurement officers, and device manufacturers to capture firsthand perspectives on clinical challenges and market realities.

Quantitative data points were triangulated across multiple vendor databases to ensure accuracy and consistency. We applied a structured segmentation framework covering product categories, procedure types, indication subtypes, disease conditions, and end-user settings. Regional analyses were informed by healthcare infrastructure indices, reimbursement landscape assessments, and epidemiological data on gastrointestinal cancers.

Competitive dynamics were mapped through detailed company profiling, encompassing R&D pipelines, strategic alliances, and recent M&A activity. All findings were subjected to internal validation workshops with a panel of industry experts to refine conclusions and ensure practical relevance. This methodological rigor underpins the credibility of our insights and supports confident decision-making by stakeholders operating in the endoscopic submucosal dissection market.

Synthesizing Insights to Chart the Path Ahead

As the endoscopic submucosal dissection market matures, stakeholders stand at a pivotal juncture. Technological innovations, shifting reimbursement paradigms, and evolving clinical practices are converging to redefine how early gastrointestinal lesions are managed. The detailed segmentation analysis illuminates priority areas for investment, while regional insights highlight the necessity of tailored market approaches.

The impact of new tariffs underscores the importance of supply chain agility and strategic sourcing. Meanwhile, competitive intelligence on leading companies reveals the critical role of collaboration, differentiation, and digital enhancement in securing market leadership. By integrating these insights, decision-makers can chart pathways that balance short-term performance with long-term value creation.

Ultimately, the successful navigation of this dynamic landscape demands an informed and proactive stance. Leveraging the comprehensive evidence and strategic recommendations outlined herein will enable manufacturers, healthcare providers, and investors to capitalize on the immense potential of endoscopic submucosal dissection, delivering superior patient outcomes and sustainable commercial growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Accessory Devices
      • Cap & Hood
      • Forceps & Clips
      • Injection Needles
      • Insufflations Units
      • Knives
        • Dual
        • Flex
        • Hook
        • Insulation-tipped
        • Triangle-tipped
      • Trocars
    • Endoscopy Devices
      • Colonoscopes
      • Duodenoscopes
      • Gastroscopes
  • Procedure Type
    • Full-Thickness Resection
    • Hybrid ESD
    • Partial-Thickness Resection
  • Indication Type
    • Colorectal Cancer
    • Early Gastric Cancer
      • Diffuse Type
      • Intestinal Type
    • Esophageal Cancer
    • Gastric Cancer
  • Disease Condition
    • Benign Tumors
    • Malignant Tumors
      • Invasive
      • Non-Invasive
    • Polyps
  • End-User Type
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Ambu A/S
  • Angelus Medical and Optical Co. Inc.
  • Aohua Endoscopy Co., Ltd.
  • Beijing ZKSK Technology Co., Ltd.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Group Incorporated
  • EndoMed Systems GmbH
  • Endoss GmbH
  • Erbe Elektromedizin GmbH
  • Etsy, Inc.
  • Flexicare Medical Ltd.
  • Fujifilm Holdings Corporation
  • Guangzhou Happycare Electronics Co., Ltd.
  • Hangzhou AGS MedTech Co., Ltd.
  • Hoya Corporation
  • Huger Medical Instrument Co., Ltd.
  • Interscope, Inc.
  • Jiangsu Maslech Medical Technology Co., Ltd.
  • Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • Karl Storz SE & Co. KG
  • Leo Medical Co. Ltd.
  • Medi-Globe GmbH by DCC Healthcare
  • Medtronic PLC
  • Micro-Tech Endoscopy
  • Mizuho America, Inc.
  • MTW-Endoskopie W. Haag KG
  • Olympus Corporation
  • Ovesco Endoscope AG
  • Richard Wolf GmbH
  • SonoScape Medical Corp.
  • Steris Corporation
  • Zeon Medical Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Endoscopic Submucosal Dissection Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population coupled with rising incidences of cancer
5.1.1.2. Favorable reimbursement policies for endoscopic procedures
5.1.1.3. Growing adoption of minimally invasive surgeries across the globe
5.1.2. Restraints
5.1.2.1. High capital and maintenance cost of endoscopic submucosal dissection procedures
5.1.3. Opportunities
5.1.3.1. Increasing number of approvals for endoscopic submucosal dissection techniques
5.1.3.2. Technological advancements in endoscopic submucosal dissection techniques and devices
5.1.4. Challenges
5.1.4.1. Side effects associated with postoperative infection of endoscopic submucosal dissection procedures
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Endoscopic Submucosal Dissection Market, by Product
6.1. Introduction
6.2. Cap & Hood
6.3. Forceps & Clips
6.4. Gastroscopes & Colonoscopes
6.5. Knives
6.6.1. Dual
6.6.2. Flex
6.6.3. Hook
6.6.4. Insulation-tipped
6.6.5. Needle
6.6.6. Triangle-tipped
7. Endoscopic Submucosal Dissection Market, by Indication
7.1. Introduction
7.2. Colon & Rectum Cancer
7.3. Esophageal Cancer
7.4. Stomach Cancer
8. Endoscopic Submucosal Dissection Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centres
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Endoscopic Submucosal Dissection Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Endoscopic Submucosal Dissection Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Endoscopic Submucosal Dissection Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
12.3.2. New Product Launch & Enhancement
12.3.2.1. Olympus in $370M buy of Taewoong to expand in gastrointestinal endotherapy field
12.3.2.2. Fujifilm expands endoscopy solutions for gastrointestinal applications
12.3.2.3. Medtronic launches AI-driven endoscopy module to detect, treat colorectal cancer
12.3.3. Investment & Funding
12.3.3.1. Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
12.3.4. Award, Recognition, & Expansion
12.3.4.1. Olympus Announces EMEA Expansion of Exclusive Partnership with EndoClot Plus, Inc.
12.3.4.2. Lumendi Receives 510(k) Clearance for Two Endoscopy Devices
12.3.4.3. Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Advanced Endoscopy Devices, Inc.
13.1.2. Ambu A/S
13.1.3. Angelus Medical and Optical
13.1.4. Anrei Medical
13.1.5. Aohua Endoscopy Co., Ltd.
13.1.6. Aspen Surgical
13.1.7. Avante Medical Surgical
13.1.8. Beijing ZKSK Technology Co., Ltd.
13.1.9. Boston Scientific Corporation
13.1.10. ConMed Corporation
13.1.11. Cook Group Incorporated
13.1.12. Creo Medical
13.1.13. Duomed Group
13.1.14. EndoMed Systems GmbH
13.1.15. Endoss GmbH
13.1.16. Erbe Elektromedizin GmbH
13.1.17. Etsy, Inc.
13.1.18. Flexicare Medical Ltd.
13.1.19. Fujifilm Holdings Corporation
13.1.20. Guangzhou Happycare Electronics Co., Ltd.
13.1.21. Hangzhou AGS MedTech Co., Ltd.
13.1.22. HMB Endoscopy Products
13.1.23. Hoya Corporation
13.1.24. Huger Medical Instrument Co., Ltd.
13.1.25. Interscope, Inc.
13.1.26. Jiangsu Maslech Medical Technology Co., Ltd.
13.1.27. Jiangsu Vedkang Medical Science and Technology Co., Ltd.
13.1.28. Karl Storz SE & Co. KG
13.1.29. Lenox Instrument Company
13.1.30. Leo Medical Co. Ltd.
13.1.31. Medi-Globe GmbH by DCC Healthcare
13.1.32. MedTec Applications, Inc.
13.1.33. Medtronic PLC
13.1.34. Micro-Tech Endoscopy
13.1.35. MicroAire Surgical Instruments, LLC
13.1.36. Mizuho America, Inc.
13.1.37. MTW-Endoskopie W. Haag KG
13.1.38. Olympus Corporation
13.1.39. Optim LLC
13.1.40. Ovesco Endoscope AG
13.1.41. Port Macquarie Gastroenterology
13.1.42. Pride Medical Instruments Technology Jiangsu Co., Ltd.
13.1.43. Richard Wolf Industrial
13.1.44. SonoScape Medical Corp.
13.1.45. Steris Corporation
13.1.46. Sumitomo Bakelite Co., Ltd.
13.1.47. Taewoong Medical
13.1.48. The Surgical Company
13.1.49. Vector Medical
13.1.50. Zeon Medical Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET RESEARCH PROCESS
FIGURE 2. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2023 VS 2030
FIGURE 3. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET DYNAMICS
FIGURE 7. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES & COLONOSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 11. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 18. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLON & RECTUM CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STOMACH CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 40. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 62. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. INDIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. INDIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 66. INDIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. INDIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. JAPAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. JAPAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 74. JAPAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. JAPAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. THAILAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. THAILAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 98. THAILAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. THAILAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. DENMARK ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 111. DENMARK ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. EGYPT ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. EGYPT ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 115. EGYPT ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. FINLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. FINLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 119. FINLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. FINLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 123. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 135. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. NORWAY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. NORWAY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 147. NORWAY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. NORWAY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. POLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. POLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 151. POLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. POLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. QATAR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. QATAR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 155. QATAR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. QATAR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SPAIN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SPAIN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 171. SPAIN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. TURKEY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. TURKEY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 183. TURKEY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. TURKEY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 194. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET LICENSE & PRICING

Companies Mentioned

The companies profiled in this Endoscopic Submucosal Dissection market report include:
  • Ambu A/S
  • Angelus Medical and Optical Co. Inc.
  • Aohua Endoscopy Co., Ltd.
  • Beijing ZKSK Technology Co., Ltd.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Group Incorporated
  • EndoMed Systems GmbH
  • Endoss GmbH
  • Erbe Elektromedizin GmbH
  • Etsy, Inc.
  • Flexicare Medical Ltd.
  • Fujifilm Holdings Corporation
  • Guangzhou Happycare Electronics Co., Ltd.
  • Hangzhou AGS MedTech Co., Ltd.
  • Hoya Corporation
  • Huger Medical Instrument Co., Ltd.
  • Interscope, Inc.
  • Jiangsu Maslech Medical Technology Co., Ltd.
  • Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • Karl Storz SE & Co. KG
  • Leo Medical Co. Ltd.
  • Medi-Globe GmbH by DCC Healthcare
  • Medtronic PLC
  • Micro-Tech Endoscopy
  • Mizuho America, Inc.
  • MTW-Endoskopie W. Haag KG
  • Olympus Corporation
  • Ovesco Endoscope AG
  • Richard Wolf GmbH
  • SonoScape Medical Corp.
  • Steris Corporation
  • Zeon Medical Inc.

Methodology

Loading
LOADING...

Table Information